<unk>  is a diagnostic agent that is FDA approved for the treatment of positron emission tomography (PET) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (CT) or magnetic resonance imaging (MRI).   Common adverse reactions include mild injection site reactions.
Choline c-11
Cyanic acid
Meconic acid
Arachidonic acid
Triethanolamine
Gamma-Linolenic acid
Cholesteryl ester
Oleic acid